Related Experiment Video
Updated: Jul 18, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Sonic Hedgehog-Gli1 signaling pathway might become an effective therapeutic target in gastrointestinal neuroendocrine
Takashi Shida1, Mitsuko Furuya, Takashi Nikaido
1Departments of Molecular Pathology, General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Abstract:
Gastrointestinal neuroendocrine carcinomas (NECs) are extremely aggressive and poorly prognostic. We showed previously that human achaete-scute homologue gene 1 (hASH1), a basic helix-loop-helix transcription factor regulated by Notch, was aberrantly expressed in NECs. To date, no effective therapeutic strategies for NECs have been investigated. Notch, Wnt and Hedgehog (Hh) signalings are important for stem cell self-renewal and carcinogenesis in the gastrointestinal epithelium. In this study, we showed that Hh signaling was clearly upregulated in NECs in Gli1-dependent manner. Specific therapeutic effects of cyclopamine on NECs were also demonstrated. RT-PCR showed that among eight frozen samples (three NECs, one carcinoid tumor, three adenocarcinomas and one normal mucosa), the band intensities of Gli1 were the strongest in NECs, moderately strong in a carcinoid tumor, very weak in adenocarcinomas and undetectable in a normal mucosa. In real-time RT-PCR, the expression levels of Gli1 in NECs were 108.4, 28.6 and 16.3 times higher than that in an adenocarcinoma. In immunohistochemistry using 25 paraffin-embedded tissues, all twelve NECs and three of six carcinoid tumors showed positive stainings for Gli1, whereas six of seven adenocarcinomas were negative. In vitro, RT-PCR showed that NEC cell lines expressed Gli1 mRNA significantly. Administration of cyclopamine suppressed cell proliferation and invasion, and induced apoptosis in NECs. In cyclopamine-treated NECs, downregulation of Gli1, Ptch1, Snail and hASH1, and upregulation of E-cadherin were demonstrated at mRNA levels. Such effects were not observed in a Gli1-negative colonic adenocarcinoma cell line or in control alkaloid-treated NECs. Hh signaling may play a crucial role in the pathophysiology of NECs. Blockade of Hh pathway using cyclopamine or its synthetic derivatives might open an effective therapeutic strategy to NECs, not only by suppressing tumor viability but also by altering tumor cell nature.
Insights
Hedgehog (Hh) signaling is upregulated in aggressive gastrointestinal neuroendocrine carcinomas (NECs). Targeting this pathway with cyclopamine suppressed NEC growth and invasion, suggesting a new therapeutic strategy.
Area of Science:
- Oncology
- Gastroenterology
- Molecular Biology
Background:
- Gastrointestinal neuroendocrine carcinomas (NECs) are highly aggressive with poor prognosis.
- Aberrant expression of human achaete-scute homologue gene 1 (hASH1) is observed in NECs.
- Notch, Wnt, and Hedgehog (Hh) signaling pathways are implicated in gastrointestinal stem cell self-renewal and carcinogenesis.
Purpose of the Study:
- To investigate the role of Hedgehog (Hh) signaling in the pathophysiology of gastrointestinal NECs.
- To evaluate the therapeutic potential of targeting Hh signaling in NECs.
Main Methods:
- Quantitative real-time RT-PCR and immunohistochemistry to assess Gli1 expression in NECs, carcinoid tumors, adenocarcinomas, and normal mucosa.
- In vitro studies using NEC cell lines treated with cyclopamine, a Hh signaling inhibitor.
- Analysis of cell proliferation, invasion, apoptosis, and gene expression changes (Gli1, Ptch1, Snail, hASH1, E-cadherin) following cyclopamine treatment.
Main Results:
- Hedgehog (Hh) signaling, indicated by Gli1 expression, was significantly upregulated in NECs compared to adenocarcinomas and normal tissues.
- Cyclopamine treatment suppressed NEC cell proliferation and invasion, and induced apoptosis in vitro.
- Cyclopamine treatment led to downregulation of Gli1, Ptch1, Snail, and hASH1, and upregulation of E-cadherin in NEC cells.
Conclusions:
- Hedgehog (Hh) signaling plays a critical role in the development and progression of gastrointestinal NECs.
- Inhibition of Hh signaling via cyclopamine demonstrates therapeutic efficacy by reducing tumor viability and altering tumor cell characteristics.
- Targeting the Hh pathway with cyclopamine or its derivatives represents a promising therapeutic strategy for NECs.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

